Stockreport

UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science [TheStreet.com]

UCB SA UNSP/ADR  (UCBJY) 
NASDAQ:AMEX Investor Relations: ucb.com/investors
PDF PR Newswire ATLANTA, April 17, 2026 Acquisition builds on UCB's 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generati [Read more]